MIDDLETOWN, CT Dec. 20, 2018 – The U.S. Pain Foundation (U.S. Pain) is continuing to implement changes to strengthen the organization after requesting the resignation of its former CEO in May. In a statement issued this week on its website and emailed to supporters, the 12 year-old organization reviewed the positive steps it’s made since learning of the financial misdeeds of the former CEO.
On Friday, December 7, the U.S. Pain Foundation shared a statement regarding the misuse of funds by the former CEO. We are limited in what additional information we can disclose at this time due to the ongoing investigation and the pending 2016 and 2017 Form 990 Information Returns, which we anticipate will be filed by the end of the year. We continue to cooperate with the authorities and are seeking restitution.
The Interagency Pain Research Coordinating Committee (IPRCC), the nation’s highest pain policy advisory committee, held its biannual meeting Oct. 23 at the National Institutes of Health (NIH) campus in Bethesda, MD. The IPRCC is the committee that oversaw the development of the National Pain Strategy, as well as the recently released Federal Pain Research Strategy. U.S. Pain Foundation’s National Director of Policy and Advocacy Cindy Steinberg, a member of the IPRCC, was in attendance.